Biotech Firms Acknowledge Minority Underrepresentation

Company officials cite an unfilled pipeline as an obstacle to recruitment; some observers see need for more aggressive recruiting. Sidebar: Helpful Resources For Minority Scientists TOO FEW: BIO president Carl Feldbaum cites the pipeline issue rather than discrimination as the main reason for small minority representation. Scientists who are members of racial and ethnic minorities are underrepresented in the biotechnology industry, according to a variety of industry observers. Minority resear

| 8 min read

Register for free to listen to this article
Listen with Speechify
0:00
8:00
Share


Company officials cite an unfilled pipeline as an obstacle to recruitment; some observers see need for more aggressive recruiting.

Sidebar: Helpful Resources For Minority Scientists

While those in the industry say the problem is quite real, it is difficult to quantify. Large and small biotechnology companies approached by The Scientist declined to provide breakdowns on the racial and ethnic makeup of their scientific staffs. And the Washington, D.C.-based Biotechnology Industry Organization (BIO), the industry's main lobbying group, does not collect data on this issue, although BIO president Carl B. Feldbaum says he plans to do so in the future.

Despite this absence of data, Feldbaum is comfortable in charging that "there are too few minority scientists in the industry." But he's quick to add, "I haven't seen any whiff of explicit discrimination. I think [the problem is caused by] the small number of minorities in the general population who have ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Robert Finn

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo
Characterizing Immune Memory to COVID-19 Vaccination

Characterizing Immune Memory to COVID-19 Vaccination

10X Genomics
Optimize PCR assays with true linear temperature gradients

Applied Biosystems™ VeriFlex™ System: True Temperature Control for PCR Protocols

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo